CBD Headlines

Today's Top Gainers

{{gainers.nyse.results.quote[0].equityinfo.longname}} (NYSE:{{gainers.nyse.results.quote[0].equityinfo.shortname}})

Last Price {{gainers.nyse.results.quote[0].pricedata.last | currency}} ˆ {{gainers.nyse.results.quote[0].pricedata.changepercent}}%

{{gainers.amex.results.quote[0].equityinfo.longname}} (AMEX:{{gainers.amex.results.quote[0].equityinfo.shortname}})

Last Price {{gainers.amex.results.quote[0].pricedata.last | currency}} ˆ {{gainers.amex.results.quote[0].pricedata.changepercent}}%

CBDNewsBreaks

CBDNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Launches Comprehensive Restructuring to Eliminate Convertible Debt and Retire 1.4 Billion Shares
Golden Triangle Ventures Inc. (GTVH)
October 16, 2025
CBDNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Completes Governance Transition, Names Javier Leal CEO and Advances Multi-Division Growth Strategy
Golden Triangle Ventures Inc. (GTVH)
August 27, 2025
CBDNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Restructures $7 Million in Legacy Debt, Secures Repurchase Option
Golden Triangle Ventures Inc. (GTVH)
July 1, 2025
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
InMed Pharmaceuticals Inc. (INM)
June 24, 2025
CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
Flora Growth Corp. (FLGC)
December 17, 2024
View More CBDNewsBreaks

CBDWire Articles

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations
Lexaria Bioscience Corp. (LEXX)
September 20, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal Study
Lexaria Bioscience Corp. (LEXX)
September 17, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study
Lexaria Bioscience Corp. (LEXX)
September 5, 2024
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy
InMed Pharmaceuticals Inc. (INM)
August 29, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market
Lexaria Bioscience Corp. (LEXX)
August 26, 2024
View All CBDWire Articles

CBDNewsAudio

CBDNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Expands Reach in Cannabis Industry to Include Processing, Manufacturing
Youngevity International, Inc. (YGYI)
July 22, 2019
CBDNewsAudio – Sugarmade, Inc. (SGMD) Providing Cultivation, Extraction Equipment as California Hemp Market Surges
Sugarmade, Inc. (SGMD)
July 18, 2019
CBDNewsAudio – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Secures Series of Noteworthy Deals with Top Retailers
Green Growth Brands Inc. (GGBXF)
July 18, 2019
CBDNewsAudio – Golden Developing Solutions Inc. (DVLP) Experiencing Strong Growth as Demand Rises in Booming Cannabis Sector
Golden Developing Solutions, Inc. (DVLP)
July 12, 2019
CBDNewsAudio – Sugarmade, Inc. (SGMD) Exploring the New Generation of Hemp Processing Technology
Sugarmade, Inc. (SGMD)
June 28, 2019
View All CBDNewsAudio

Public Press Releases

Filter Releases
Filters
Sector



Remove All Filters
Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
Load More

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

CBDWire

1108 Lavaca St
Suite 110-CBDW
Austin, TX 78701
(512) 354-7000

Copyright © . CBDWire / 1108 Lavaca St Suite 110-CBDW Austin, TX 78701 (512) 354-7000 / Disclaimers